Use and utility of Ankle brachial index in patients with diabetes

L. Potier, Charbel Abi Khalil, K. Mohammedi, R. Roussel

Research output: Contribution to journalReview article

121 Citations (Scopus)

Abstract

Ankle brachial index (ABI) is a simple method to screen peripheral arterial disease (PAD) and to evaluate cardiovascular (CV) prognosis in the general population. Measuring it requires a hand-held Doppler probe but it can be done also with an automatic device. ABI is an effective tool for clinical practice or clinical studies. However, in diabetic patients, it has some specific caveats. Sensitivity of the standard threshold of 0.9 appears to be lower in diabetic patients with complications. Moreover, highly frequent arterial medial calcifications in diabetes increase ABI. It has been demonstrated that measurements >1.3 are well correlated with both an increased prevalence of PAD and CV risk. Therefore, ABI thresholds of less than 0.9 and more than 1.3 are highly suspicious for PAD and high CV risk in diabetic patients. However, when there is concomitant clinical peripheral neuropathy or high risk of arterial calcification, the efficiency of ABI seems to be limited. In this case, other methods should be applied, toe pressure, in particular. Thus, the ABI could be used in patients with diabetes, but values should be interpreted with precision, according to the clinical situation.

Original languageEnglish
Pages (from-to)110-116
Number of pages7
JournalEuropean Journal of Vascular and Endovascular Surgery
Volume41
Issue number1
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Ankle Brachial Index
Peripheral Arterial Disease
Toes
Peripheral Nervous System Diseases
Hand
Pressure
Equipment and Supplies
Population

Keywords

  • Ankle brachial index
  • Cardiovascular risk
  • Diabetes
  • Peripheral arterial disease
  • Screening test

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Use and utility of Ankle brachial index in patients with diabetes. / Potier, L.; Abi Khalil, Charbel; Mohammedi, K.; Roussel, R.

In: European Journal of Vascular and Endovascular Surgery, Vol. 41, No. 1, 2011, p. 110-116.

Research output: Contribution to journalReview article

@article{2018bebac7cd4bafb12afafec735ddf6,
title = "Use and utility of Ankle brachial index in patients with diabetes",
abstract = "Ankle brachial index (ABI) is a simple method to screen peripheral arterial disease (PAD) and to evaluate cardiovascular (CV) prognosis in the general population. Measuring it requires a hand-held Doppler probe but it can be done also with an automatic device. ABI is an effective tool for clinical practice or clinical studies. However, in diabetic patients, it has some specific caveats. Sensitivity of the standard threshold of 0.9 appears to be lower in diabetic patients with complications. Moreover, highly frequent arterial medial calcifications in diabetes increase ABI. It has been demonstrated that measurements >1.3 are well correlated with both an increased prevalence of PAD and CV risk. Therefore, ABI thresholds of less than 0.9 and more than 1.3 are highly suspicious for PAD and high CV risk in diabetic patients. However, when there is concomitant clinical peripheral neuropathy or high risk of arterial calcification, the efficiency of ABI seems to be limited. In this case, other methods should be applied, toe pressure, in particular. Thus, the ABI could be used in patients with diabetes, but values should be interpreted with precision, according to the clinical situation.",
keywords = "Ankle brachial index, Cardiovascular risk, Diabetes, Peripheral arterial disease, Screening test",
author = "L. Potier and {Abi Khalil}, Charbel and K. Mohammedi and R. Roussel",
year = "2011",
doi = "10.1016/j.ejvs.2010.09.020",
language = "English",
volume = "41",
pages = "110--116",
journal = "European Journal of Vascular and Endovascular Surgery",
issn = "1078-5884",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Use and utility of Ankle brachial index in patients with diabetes

AU - Potier, L.

AU - Abi Khalil, Charbel

AU - Mohammedi, K.

AU - Roussel, R.

PY - 2011

Y1 - 2011

N2 - Ankle brachial index (ABI) is a simple method to screen peripheral arterial disease (PAD) and to evaluate cardiovascular (CV) prognosis in the general population. Measuring it requires a hand-held Doppler probe but it can be done also with an automatic device. ABI is an effective tool for clinical practice or clinical studies. However, in diabetic patients, it has some specific caveats. Sensitivity of the standard threshold of 0.9 appears to be lower in diabetic patients with complications. Moreover, highly frequent arterial medial calcifications in diabetes increase ABI. It has been demonstrated that measurements >1.3 are well correlated with both an increased prevalence of PAD and CV risk. Therefore, ABI thresholds of less than 0.9 and more than 1.3 are highly suspicious for PAD and high CV risk in diabetic patients. However, when there is concomitant clinical peripheral neuropathy or high risk of arterial calcification, the efficiency of ABI seems to be limited. In this case, other methods should be applied, toe pressure, in particular. Thus, the ABI could be used in patients with diabetes, but values should be interpreted with precision, according to the clinical situation.

AB - Ankle brachial index (ABI) is a simple method to screen peripheral arterial disease (PAD) and to evaluate cardiovascular (CV) prognosis in the general population. Measuring it requires a hand-held Doppler probe but it can be done also with an automatic device. ABI is an effective tool for clinical practice or clinical studies. However, in diabetic patients, it has some specific caveats. Sensitivity of the standard threshold of 0.9 appears to be lower in diabetic patients with complications. Moreover, highly frequent arterial medial calcifications in diabetes increase ABI. It has been demonstrated that measurements >1.3 are well correlated with both an increased prevalence of PAD and CV risk. Therefore, ABI thresholds of less than 0.9 and more than 1.3 are highly suspicious for PAD and high CV risk in diabetic patients. However, when there is concomitant clinical peripheral neuropathy or high risk of arterial calcification, the efficiency of ABI seems to be limited. In this case, other methods should be applied, toe pressure, in particular. Thus, the ABI could be used in patients with diabetes, but values should be interpreted with precision, according to the clinical situation.

KW - Ankle brachial index

KW - Cardiovascular risk

KW - Diabetes

KW - Peripheral arterial disease

KW - Screening test

UR - http://www.scopus.com/inward/record.url?scp=78650817743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650817743&partnerID=8YFLogxK

U2 - 10.1016/j.ejvs.2010.09.020

DO - 10.1016/j.ejvs.2010.09.020

M3 - Review article

VL - 41

SP - 110

EP - 116

JO - European Journal of Vascular and Endovascular Surgery

JF - European Journal of Vascular and Endovascular Surgery

SN - 1078-5884

IS - 1

ER -